List of Dynavax Technologies patents

Patents where

Current Assignee

Name

Dynavax Technologies

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7157437 Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences	Patent 7157437 was granted and assigned to Dynavax Technologies on January, 2007 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7157437	January 2, 2007
‌ US Patent 7718622 Compositions comprising structurally stable conjugate molecules	Patent 7718622 was granted and assigned to Dynavax Technologies on May, 2010 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7718622	May 18, 2010
‌ US Patent 7628990 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof	Patent 7628990 was granted and assigned to Dynavax Technologies on December, 2009 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7628990	December 8, 2009
‌ US Patent 8962579 Methods and compositions for inhibition of immune responses and autoimmunity	Patent 8962579 was granted and assigned to Dynavax Technologies on February, 2015 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	8962579	February 24, 2015
‌ US Patent 11124510 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof	Patent 11124510 was granted and assigned to Dynavax Technologies on September, 2021 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	11124510	September 21, 2021
‌ US Patent 8124590 Biodegradable immunomodulatory formulations and methods for use thereof	Patent 8124590 was granted and assigned to Dynavax Technologies on February, 2012 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	8124590	February 28, 2012
‌ US Patent 8940310 Methods of treatment using TLR7 and/or TLR9 inhibitors	Patent 8940310 was granted and assigned to Dynavax Technologies on January, 2015 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	8940310	January 27, 2015
‌ US Patent 7884083 Immunomodulatory compositions, methods of making, and methods of use thereof	Patent 7884083 was granted and assigned to Dynavax Technologies on February, 2011 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7884083	February 8, 2011
‌ US Patent 7129222 Immunomodulatory formulations and methods for use thereof	Patent 7129222 was granted and assigned to Dynavax Technologies on October, 2006 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7129222	October 31, 2006
‌ US Patent 7183111 Immunomodulatory formulations and methods for use thereof	Patent 7183111 was granted and assigned to Dynavax Technologies on February, 2007 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7183111	February 27, 2007
‌ US Patent 7250403 Biodegradable immunomodulatory formulations and methods for use thereof	Patent 7250403 was granted and assigned to Dynavax Technologies on July, 2007 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7250403	July 31, 2007
‌ US Patent 9868955 Human toll-like receptor inhibitors and methods of use thereof	Patent 9868955 was granted and assigned to Dynavax Technologies on January, 2018 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	9868955	January 16, 2018
‌ US Patent 10196643 Immunostimulatory sequence oligonucleotides and methods of using the same	Patent 10196643 was granted and assigned to Dynavax Technologies on February, 2019 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	10196643	February 5, 2019
‌ US Patent 7479285 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein	Patent 7479285 was granted and assigned to Dynavax Technologies on January, 2009 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7479285	January 20, 2009
‌ US Patent 9422564 Immunostimulatory sequence oligonucleotides and methods of using the same	Patent 9422564 was granted and assigned to Dynavax Technologies on August, 2016 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	9422564	August 23, 2016
‌ US Patent 7745606 Immunostimulatory sequence oligonucleotides and methods of using the same	Patent 7745606 was granted and assigned to Dynavax Technologies on June, 2010 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7745606	June 29, 2010
‌ US Patent 7785610 Chimeric immunomodulatory compounds and methods of using the same—III	Patent 7785610 was granted and assigned to Dynavax Technologies on August, 2010 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7785610	August 31, 2010
‌ US Patent 8372413 Immunomodulatory polynucleotides and methods of using the same	Patent 8372413 was granted and assigned to Dynavax Technologies on February, 2013 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	8372413	February 12, 2013
‌ US Patent 8158768 Immunostimulatory sequence oligonucleotides and methods of using the same	Patent 8158768 was granted and assigned to Dynavax Technologies on April, 2012 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	8158768	April 17, 2012
‌ US Patent 7255868 Chimeric immunomodulatory compounds and methods of using the same—I	Patent 7255868 was granted and assigned to Dynavax Technologies on August, 2007 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7255868	August 14, 2007
‌ US Patent 7625872 Branched immunomodulatory compounds and methods of using the same	Patent 7625872 was granted and assigned to Dynavax Technologies on December, 2009 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	7625872	December 1, 2009
‌ US Patent 9228184 Human toll-like receptor inhibitors and methods of use thereof	Patent 9228184 was granted and assigned to Dynavax Technologies on January, 2016 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	9228184	January 5, 2016
‌ US Patent 10350290 Linear chimeric compounds and methods of use thereof	Patent 10350290 was granted and assigned to Dynavax Technologies on July, 2019 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	10350290	July 16, 2019
‌ US Patent 9347064 Methods of treatment using TLR7 and/or TLR9 inhibitors	Patent 9347064 was granted and assigned to Dynavax Technologies on May, 2016 by the United States Patent and Trademark Office.	Dynavax Technologies	Dynavax Technologies	United States Patent and Trademark Office	9347064	May 24, 2016
‌ US Patent 8669237 Biodegradable immunomodulatory formulations and methods for use thereof	Patent 8669237 was granted and assigned to Dynavax Technologies on March, 2014 by the United States Patent and Trademark Office.		Dynavax Technologies	United States Patent and Trademark Office	8669237	March 11, 2014

Results per page:

55 results

0 selected

55 results

0 selected